Skip to main content
Help & FAQ
Home
Profiles
Research Units
Research Output
Datasets
Prizes
Activities
Press / Media
Impacts
Are anti-EGFR monoclonal antibodies the magic bullets that remove circulating tumor cells in patients with non-small cell lung cancer (NSCLC)?
Marjolein van Egmond
(Recipient)
Molecular cell biology
Surgery
AG&M - Digestive immunity
AG&M - Re-generation and cancer of the digestive system
CCA - Cancer biology and immunology
CCA - Imaging and biomarkers
CCA - Treatment and quality of life
I&I - Inflammatory diseases
Prize
Description
(€175.000).
Awarded date
2018
Degree of recognition
National
Organisations
Koningin Wilhelmina Fonds (KWF)